About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Self-sampling to Optimize Anal Lesion Outcomes | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNANCT07192055

Self-sampling to Optimize Anal Lesion Outcomes

The purpose of this research study is to find ways to increase anal cancer screening among people at increased risk for anal cancer. This study will try to find out if persons will do an intervention ...

Lead sponsor: Medical College of Wisconsin•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Alan G Nyitray, PhD

CONTACT

4149557701 anyitray@mcw.edu

Jenna Nitkowski, PhD

CONTACT

414-955-2126 jnitkowski@mcw.edu

Sponsors

Lead Sponsor

Medical College of Wisconsin

Collaborators

National Cancer Institute (NCI)
University of Chicago
Froedtert Hospital
M.D. Anderson Cancer Center

Age

35 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Age ≥ 35 years for those who are HIV-positive or ≥ 45 years for those who are HIV-negative.
•2. Must be either:
•1. A cisgender or transgender sexual minority man, or
•2. A transgender woman who has sex with men.
•3. Resides in Chicago, Houston, or Milwaukee metropolitan area.
•4. Is willing to attend a study clinic.
•5. Speak and understand either English or Spanish
•6. Ability to understand a written informed consent document, and the willingness to sign it.

Exclusion Criteria

•1. Was a participant in the PAC Self-Swab Study in Milwaukee.
•2. Currently on anticoagulants, with the exception of aspirin or non-steroidal anti-inflammatory drugs (NSAIDs), e.g., ibuprofen, naproxen.
•3. Diagnosed with hemophilia, cirrhosis with bleeding varices, or thrombocytopenia.
•4. Presence of any contraindicating severe disease or condition, e.g., anal stenosis.
•5. Plans to move within 12 months after enrollment.

Related studies

DESTINY-PANTUMOUR04

NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more

Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy

NCT04094454 · Anal Cancer

RECRUITINGPhase 1/2

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

NCT05639972 · HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, and more

RECRUITINGPhase 2

Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes

NCT06640283 · HPV-Related Carcinoma, Uterine Cervical Cancer, and more

RECRUITINGPhase 2

Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer

NCT05040815 · Anal Canal Cancer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 16, 2026Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment572

Start dateNov 2025

Last updatedApr 16, 2026

Condition

Locations shown

University of Chicago

Chicago, Illinois

The University of Texas M.D. Anderson Cancer Center

Houston, Texas

Medical College of Wisconsin

Milwaukee, Wisconsin

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 16, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions